ANGINOVAG

This brand name is authorized in Spain

Active ingredients

The drug ANGINOVAG contains a combination of these active pharmaceutical ingredients (APIs):

1 Enoxolone
UNII P540XA09DR - ENOXOLONE

Enoxolone is a pentacyclic triterpenoid aglycone metabolite of glycyrrhizin, which is a product of the plant Glycyrrhiza glabra (licorice), with potential expectorant, and gastrokinetic activities. After administration, enoxolone inhibits the metabolism of prostaglandins by both 15-hydroxyprostaglandin dehydrogenase [NAD] and prostaglandin reductase 2.

Read about Enoxolone
2 Tyrothricin
UNII 877376V2XW - TYROTHRICIN

Tyrothricin is a circular polypeptide with antibiotic and bacteriostatic activity. It is effective against gram-positive bacteria.

Read about Tyrothricin
3 Lidocaine
UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.

Read about Lidocaine
4 Hydrocortisone
UNII 3X7931PO74 - HYDROCORTISONE ACETATE

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.

Read about Hydrocortisone
5 Dequalinium
UNII XYS8INN1I6 - DEQUALINIUM CHLORIDE

Dequalinum is an anti-infective and antiseptic agent belonging to the class of quaternary ammonium compounds. The primary mechanism of action is an increase in bacterial cell permeability and the subsequent loss of enzyme activity, finally resulting in cell death.

Read about Dequalinium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R02AA Antiseptics R Respiratory system → R02 Throat preparations → R02A Throat preparations
Discover more medicines within R02AA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 37453

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.